GlassScriptPhysician profile
Nicholas Ray Rowan
NPI 1225392558
$24,990.45
in general payments reported to CMS, 2019-2025
12 companies · $1,968 in 2025
The $1,968 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $665 · 2021: $2,136 · 2022: $253 · 2023: $7,693 · 2024: $10K · 2025: $1,968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $1,110 · Travel and Lodging: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,213.42 |
| Food and Beverage | $1,110.28 |
| Travel and Lodging | $796.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $11,210.22 | 2024-2025 | |
| Ethicon INC. | $8,315.05 | 2023-2024 | |
| Medtronic, INC. | $2,773.75 | 2020-2025 | Fusion, Propel |
| Optinose US, INC. | $1,447.21 | 2019 | |
| Stryker Corporation | $552.75 | 2020-2025 | Core |
| Neurent Medical Limited | $237.95 | 2022 | |
| Acclarent, INC | $123.65 | 2019-2022 | |
| Organogenesis INC. | $122.46 | 2019 | |
| Intersect Ent, INC. | $100.00 | 2019 | |
| Cook Medical LLC | $93.02 | 2019 | |
| Alk-Abello, INC | $14.39 | 2023 | Timothy, Standardized, Alternaria Tenuis, Standardized Mite D. Farinae |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.